Literature DB >> 10597900

Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones.

H G Shertzer1, A Puga, C Chang, P Smith, D W Nebert, K D Setchell, T P Dalton.   

Abstract

The mechanisms by which soybean- and soybean isoflavone-enriched diets inhibit carcinogenesis are not known. We found that the isoflavones genistin and daidzin, and their respective aglucone forms daidzein and genistein, block 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dioxin)-induced CYP1A1 enzyme activity. This inhibition is correlated with the capacity of the isoflavones to prevent CYP1A1-mediated covalent binding of benzo[a]pyrene (BaP) metabolites to DNA. We further evaluated daidzein and genistein, believed to be the active forms of the isoflavones, for the mechanism of the inhibitory process. Although daidzein and genistein appear structurally similar to known aromatic hydrocarbon receptor (AHR) agonists and antagonists, gel mobility shift assays indicated that the isoflavones do not inhibit dioxin-induced activation of the AHR or the accumulation of CYP1A1 mRNA, suggesting that the isoflavones do not act at the transcriptional level. We therefore evaluated the isoflavones for direct effects on the CYP1A1 enzyme. Daidzein and genistein non-competitive with the CYP1A1 substrate BaP for microsomal BaP hydroxylation, with apparent Ki values of 325 microM and 140 microM, respectively. The extent of CYP1A1 inhibition increases with time of preincubation at 37 degrees C, but not at 4 degrees C, in the presence of isoflavone plus NADPH; after 60 min preincubation the inhibition remains non-competitive, with apparent Ki values of 55 microM and 50 microM, respectively. Inhibition is neither prevented nor reversed by the thiol antioxidant dithiothreitol, nor by the iron chelator deferoxamine. Repeated washing of the microsomes does not reverse the inhibition. The dependency on NADPH, temperature and time for inhibition of CYP1A1 suggests that metabolism of either isoflavone or molecular oxygen to reactive species is required. Isoflavone-mediated inhibition of CYP1A1 activity may contribute to the mechanism by which these soybean isoflavones protect against carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597900     DOI: 10.1016/s0009-2797(99)00121-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  10 in total

1.  Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context.

Authors:  Richard J Wall; Guochun He; Michael S Denison; Cenzo Congiu; Valentina Onnis; Alwyn Fernandes; David R Bell; Martin Rose; J Craig Rowlands; Gianfranco Balboni; Ian R Mellor
Journal:  Toxicology       Date:  2012-04-07       Impact factor: 4.221

2.  Molecular mechanisms of cold-induced CYP1A activation in rat liver microsomes.

Authors:  Maria Perepechaeva; Natalia Kolosova; Alevtina Grishanova
Journal:  J Physiol Biochem       Date:  2011-04-20       Impact factor: 4.158

3.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.

Authors:  L M Scott; P Durant; S Leone-Kabler; C E Wood; T C Register; A Townsend; J M Cline
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-08       Impact factor: 4.292

4.  Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis).

Authors:  Latanya M Scott; Xia Xu; Timothy D Veenstra; Janet A Tooze; Charles E Wood; Thomas C Register; Nancy D Kock; J Mark Cline
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 5.  Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

Authors:  Svjetlana Medjakovic; Monika Mueller; Alois Jungbauer
Journal:  Nutrients       Date:  2010-02-26       Impact factor: 5.717

Review 6.  Genistein: does it prevent or promote breast cancer?

Authors:  K B Bouker; L Hilakivi-Clarke
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

7.  Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals.

Authors:  Erin L Hsu; Natalie Chen; Aya Westbrook; Feng Wang; Ruixue Zhang; Robert T Taylor; Oliver Hankinson
Journal:  J Oncol       Date:  2009-03-24       Impact factor: 4.375

8.  Epigenetics and breast cancers.

Authors:  An T Vo; Richard M Millis
Journal:  Obstet Gynecol Int       Date:  2012-04-10

9.  Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.

Authors:  Shu Zhang; Chunhua Qin; Stephen H Safe
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

Review 10.  Phytoestrogens and breast cancer prevention: possible mechanisms of action.

Authors:  Sarah M Mense; Tom K Hei; Ramesh K Ganju; Hari K Bhat
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.